Sinovac Biotech Ltd. has received GMP certification from the China’s State Food and Drug Administration (SFDA) for its filling and packaging production facility. The certificate of compliance was issued following a site inspection and has a five-year term. The GMP certification provides for an overall annual production capacity of 20 million doses, with the capability to produce as many as 40 million doses. This certification allows Sinovac to meet current and potential production increases f...